Vol 8, No 4 (2023)
Letter to the Editor
Published online: 2023-09-18
A new method of treating type 1 diabetes — a closed-loop system
DOI: 10.5603/mrj.97386
Medical Research Journal 2023;8(4):322-323.
Abstract
Not available
References
- Atkinson MA, Eisenbarth GS, Michels AW. Type 1 diabetes. Lancet. 2014; 383(9911): 69–82.
- Norris JM, Johnson RK, Stene LC. Type 1 diabetes-early life origins and changing epidemiology. Lancet Diabetes Endocrinol. 2020; 8(3): 226–238.
- Dovc K, Boughton C, Tauschmann M, et al. APCam11, AP@Home, and KidsAP Consortia. Young Children Have Higher Variability of Insulin Requirements: Observations During Hybrid Closed-Loop Insulin Delivery. Diabetes Care. 2019; 42(7): 1344–1347.
- Miller KM, Foster NC, Beck RW, et al. T1D Exchange Clinic Network. Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry. Diabetes Care. 2015; 38(6): 971–978.
- DiMeglio LA, Evans-Molina C, Oram RA. Type 1 diabetes. Lancet. 2018; 391(10138): 2449–2462.
- Breton MD, Kanapka LG, Beck RW, et al. iDCL Trial Research Group. A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes. N Engl J Med. 2020; 383(9): 836–845.
- Fuchs J, Hovorka R. Closed-loop control in insulin pumps for type-1 diabetes mellitus: safety and efficacy. Expert Rev Med Devices. 2020; 17(7): 707–720.
- Karakuş K. Effects of Diabetes Technologies on Decision Making Feedback Loop in Type 1 Diabetes. Clinical Diabetology. 2023; 12(1): 71–73.
- Abraham MB, de Bock M, Smith GJ, et al. Australian Juvenile Diabetes Research Fund Closed-Loop Research group. Effect of a Hybrid Closed-Loop System on Glycemic and Psychosocial Outcomes in Children and Adolescents With Type 1 Diabetes: A Randomized Clinical Trial. JAMA Pediatr. 2021; 175(12): 1227–1235.